Fig. 3

Decrease in ADMA concentration in relation to the number of delivered BM-MNCs at 3 months after cell delivery. ADMA asymmetric dimethylarginine, BM-MNC bone marrow-derived mononuclear cell
Decrease in ADMA concentration in relation to the number of delivered BM-MNCs at 3 months after cell delivery. ADMA asymmetric dimethylarginine, BM-MNC bone marrow-derived mononuclear cell